The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead ...

Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Users are changing the ways they spend on food, clothes and health and beauty products, as well as how they eat out.

By Amina Niasse NEW YORK, June 11 (Reuters) - Some employers are planning to drop coverage of GLP-1 drugs for weight loss next year as more people take the medications, counteracting some savings from ...

People taking GLP-1 weight-loss medications aren’t suddenly swearing off casual dining. Actually, it’s the exact opposite. A ...

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to ...

Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing ...

Scott Galloway and Ed Elson laid out the math on Prof G Markets and it should make every fast food shareholder uneasy: ...

A study of more than 110,000 women found those who took popular GLP-1 drugs prescribed for obesity or diabetes had a lower ...

GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.

The Florida -based grocery chain announced this week that customers can now pick up a free GLP-1-focused brochure titled ...